Delivery Order SPE2DB22D1103-SPE2DB25FTLK2
Award Date
4/29/25
Potential Completion Date
5/20/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,997.42, is for the delivery of the prescription medication INQOVI 35 MG-100 MG TABLET. This contract is a child award under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $9,660.94, is for the delivery of the specialty medication INQOVI 35 MG-100 MG TABLET with a completion date of March 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as...
This is a delivery order awarded to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, specifically the drug INQOVI 35 MG-100 MG TABLET. The contract has a firm-fixed price of $14,491.41 and a completion date of September 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,119.36 firm fixed-price contract is for the delivery of INQOVI 35 MG-100 MG TABLET UU 5S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen is the prime contractor, with no major subcontractors mentioned. The award is not associated with a specific set-aside...
This is a $5,119.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $4,830.47, is for the delivery of the prescription medication INQOVI 35 MG-100 MG TABLET. The contract has a firm fixed price pricing type and an ultimate completion date of May 23, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide INQOVI 35 MG-100 MG tablets. The $4,830.47 contract has a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,119.36, is for the delivery of the pharmaceutical product INQOVI 35 MG-100 MG TABLET. It is a Firm Fixed Price Delivery Order contract, with a completion date of February 6, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of INQOVI 35 MG-100 MG tablets, a pharmaceutical product, with a ceiling value of $10,238.74 and a performance period ending on April 30, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $10,238.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, and has a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. In addition to this specific contract,...